| Zocor Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Zocor 80 mg | tablet | oral | 1.0 each | OTC |
| Zocor 5 mg | tablet | oral | 1.0 each | OTC |
| Zocor 10 mg | tablet | oral | 1.0 each | OTC |
| Zocor 20 mg | tablet | oral | 1.0 each | OTC |
| Zocor 40 mg | tablet | oral | 1.0 each | OTC |
Posted by proma55 2 days ago
Same here folks. I've been on Zocor for 2 months and have a constant pain in my left leg on the side of my calf. Always the...
Posted by mom2alex 9 days ago
I am a 58-year-old woman that changed from zetia to zocor about 6 months ago because of the price of zetia AND I had tolerate...
Posted by ilbvacumin 12 days ago
I'm a 54y/o female prescribed zocor for slightly elevated cholesterol. Too it for 7 months before I clued in to the cause o...
Lipitor's pitchman gets axed - International Herald Tribune
Pfizer turned to Jarvik because Lipitor, the world's best-selling drug, is losing market share to a generic version of a competing cholesterol drug, Zocor, ...
Mon Mar 10 12:13:19 -0400 2008
Drug Makers Increased Prices By Average Of 7.4% In 2007 For ... - Medical News Today (press release)
The drug with the largest price increase -- 27.7% -- was Sanofi-Aventis' sleep aid Ambien, while the price of Merck's cholesterol drug Zocor did not change. ...
Thu Mar 06 14:04:00 -0500 2008
Drug Makers Increased Prices by Average of 7.4% in 2007 for ... - Kaiser network.org
The drug with the largest price increase -- 27.7% -- was Sanofi-Aventis' sleep aid Ambien, while the price of Merck's cholesterol drug Zocor did not change. ...
Wed Mar 05 11:35:38 -0500 2008
simvastatin - A lipid-lowering agent derived synthetically from a fermentation product of the fungus Aspergillus terreus. Hydrolyzed in vivo to an active metabolite, simvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04)